China’s Slowdown Pressures Japanese Businesses in 2026
Business confidence remains weak as competition intensifies
Following recent remarks by Sanae Takaichi, Japan’s Minister of State for Economic Security, highlighting growing concerns over China’s economic slowdown and its impact on Japanese companies, attention has increasingly turned to how businesses should reposition themselves in the Chinese market.
Against this backdrop,key industries—including automobiles, semiconductors, robotics, chemicals, and pharmaceuticals—are being closely examined to assess current operating conditions and to evaluate how Japanese companies may need to adjust their strategies in China in the years ahead.
With China’s economic momentum weakening, bilateral relations remaining strained since late 2025, and local competitors rapidly strengthening their technological and cost advantages, business confidence among Japanese firms in China remains subdued heading into 2026.
Automobiles: Weak demand and intensifying price competition
The automotive sector is among the hardest hit. China’s economic slowdown has coincided with a rapid shift toward new energy vehicles (NEVs), where domestic Chinese automakers hold strong cost and scale advantages.
Japanese automakers have seen their market position erode in recent years. Honda Motor’s annual production capacity in China stands at approximately 1.2 million vehicles, yet its sales in 2025 totaled only around 640,000 units. Toyota Motor, Nissan Motor and Honda all reported year-on-year declines in new car sales in China in December 2025.
Demand for new vehicles has also softened across the broader market. According to research firm MarkLines, BYD’s new car sales in China declined for six consecutive months through December 2025 compared with the same period a year earlier.
Looking ahead, prospects for 2026 remain challenging. Masakazu Matsumoto, CEO of AESC Japan, which manufactures EV batteries, noted that while China’s NEV market will remain relatively robust, overall automobile demand is unlikely to grow significantly due to weak macroeconomic conditions.
Suppliers are feeling similar pressure. Parts manufacturers report intense price competition from local firms, with some Japanese suppliers considering withdrawal from the Chinese market. Industry sources suggest that only a handful of Japanese automakers may be able to sustain long-term operations without significant restructuring.
At the same time, Japanese automakers are attempting a counteroffensive. Nissan’s new affordable EV sedan, the N7, has gained traction by leveraging locally sourced components to lower costs, while Honda is focusing on enhancing driver-assistance and safety technologies to differentiate its offerings. The challenge remains balancing cost competitiveness with functional and technological differentiation.
Nissan's new, affordable EV sedan, the N7, is selling well
Semiconductors: Chinese players gain ground
Competition in semiconductors is intensifying as Chinese manufacturers rapidly expand capabilities, particularly in power and analog semiconductors. Chinese automakers are increasingly switching to domestically produced chips, putting pressure on Japanese, European and US suppliers.
Industry insiders point to companies such as Hangzhou Silan Microelectronics as having achieved notable strength in intelligent power modules used in inverter control systems. Market share losses have been reported for several Japanese suppliers, including those traditionally strong in automotive semiconductors.
China’s ambitions extend beyond mature technologies. Under its 15th Five-Year Plan, starting in 2026, the government aims to accelerate domestic production of advanced semiconductors and manufacturing equipment. At new facilities such as those being built by Yangtze Memory Technologies Co. (YMTC), the majority of installed equipment is already sourced from Chinese manufacturers, with only a limited number of critical tools still reliant on imports.
Industry observers note that China’s rapid progress is reshaping the global semiconductor ecosystem, forcing Japanese firms to reconsider how they collaborate, compete and position themselves within an increasingly self-sufficient Chinese supply chain.
China's power semiconductors are rapidly gaining strength (Hangzhou Shilan Microelectronics base)
Robotics: Domestic manufacturers dominate volume growth
China remains the world’s largest robotics market, driven by strong automation demand. According to the International Federation of Robotics (IFR), 295,000 robots were installed in Chinese factories in 2024, accounting for 54% of global installations.
While industrial robots have long been a strength of Japanese manufacturers, Chinese firms are gaining ground rapidly with government backing and aggressive pricing strategies. Companies such as ESTUN Automation and INOVANCE Technology have expanded market share, particularly in low- and mid-priced segments.
Data from manufacturing research firm MIR shows that Chinese manufacturers accounted for 56.2% of China’s industrial robot market in the third quarter of 2025, indicating a significant shift toward domestic production.
Japanese companies are responding by emphasizing strengths in higher-end applications. FANUC, for example, continues to focus on mid- to high-range systems, differentiating through advanced control technologies, digitalization, AI and IoT integration rather than competing purely on price.
Chemicals: Local production for local consumption
The chemical industry has also undergone structural change, with several Japanese companies divesting or consolidating operations in China amid intensifying competition from local producers.
At the same time, China’s push for semiconductor self-sufficiency has opened new opportunities. Japanese chemical companies with local manufacturing bases are expanding production of semiconductor-related materials, enabling faster response to customer needs.
A growing number of firms are adopting a “local production for local consumption” strategy. Asahi Yukizai, for example, is building a new facility in Nantong scheduled for completion in March 2027, tripling its production capacity for semiconductor photoresist raw materials compared with its existing plant.
A rendering of the new Asahi Yukizai factory, scheduled for completion in March 2015
Pharmaceuticals: Collaboration amid slower growth
China remains the world’s second-largest pharmaceutical market, valued at approximately US$166 billion in 2024, according to IQVIA. However, economic slowdown and tighter pricing controls have dampened growth prospects, with average annual growth expected to slow to 1–4% through 2029.
Despite these challenges, Japanese pharmaceutical companies continue to view China as strategically important. Major firms are strengthening partnerships with local biotech companies, licensing and introducing China-developed products to supplement their pipelines.
Executives emphasize that China’s innovation ecosystem remains attractive, even as pricing pressure and regulatory complexity increase.
Strategic reassessment underway
Across industries, Japanese companies are being forced to rethink their China strategies amid prolonged economic weakness, intensifying competition and structural transformation. While some firms are scaling back or shifting focus, others are doubling down on localization, technology leadership and collaboration.
As 2026 unfolds, China is likely to remain a difficult but unavoidable market for Japanese businesses—one that demands sharper strategic focus, greater flexibility and a clear understanding of where sustainable competitiveness can still be built.
.jpg)
